Loading...

By MBN Staff - Mon, 08/04/2025 - 12:40

A Break Through Cancer study finds hidden cancer cells in 42% of ovarian cancer patients post-treatment, offering new targets for therapy.

Partnership Content

https://mexicobusiness.news/tag/targeted-therapy

More Health

By MBN Staff - Wed, 07/02/2025 - 10:58

Mexico is part of the expanding metastatic cancer therapeutics market, driven by rising cases and advances in drug approvals and treatments.

By Sofía Garduño - Mon, 06/30/2025 - 11:50

A new antibody selectively suppresses harmful T cells, offering hope for treating autoimmune diseases.

By MBN Staff - Mon, 06/09/2025 - 09:52

New therapies are improving outcomes for blood cancer patients in Mexico, with INCan emphasizing early detection and modern treatment options.

By Jorge Melendez Zajgla - Tue, 05/20/2025 - 06:00

Targeted therapies and companion diagnostics are reshaping cancer care, offering personalized and precise treatment, writes Jorge Meléndez Zajgla

By - Tue, 03/11/2025 - 08:30

From monoclonal antibodies to the evolution toward Antibody Drug Conjugates, Luis Alberto Velez looks at the future of cancer care.

By MBN Staff - Mon, 12/23/2024 - 13:39

Pfizer's BRAFTOVI, combined with cetuximab and mFOLFOX6, is FDA-approved for treating metastatic colorectal cancer with a BRAF V600E mutation.

By MBN Staff - Thu, 11/28/2024 - 11:08

FDA approves Ziihera, the first dual HER2-targeted therapy for metastatic HER2-positive BTC, marking a significant advancement in treatment.

By Anmol Motwani - Thu, 09/12/2024 - 10:51

Arvinas' vepdegestrant, a pioneering protein degrader, shows up to 97% efficacy in tumor reduction, poised for FDA approval by 2025.